ストックスクリーナーアプリを入手
31.28
0.35%
0.11
アフターアワーズ：
30.85
-0.43
-1.37%
前日終値:
$31.17
開ける：
$31.06
24時間の取引高:
4.63M
Relative Volume:
1.10
時価総額：
$13.51B
収益：
$2.27B
当期純損益:
$1.15B
株価収益率:
12.27
EPS:
2.55
ネットキャッシュフロー:
$2.80B
1週間 パフォーマンス:
-0.89%
1か月 パフォーマンス:
-7.02%
6か月 パフォーマンス:
+10.76%
1年 パフォーマンス:
+6.25%
1日の値動き範囲:
$30.82
$31.36
1週間の範囲:
$30.64
$32.25
52週間の値動き範囲:
$24.05
$34.20
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
RPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
31.28 | 13.51B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-03 | ダウングレード | UBS | Buy → Neutral |
| 2022-06-14 | 再開されました | UBS | Buy |
| 2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-30 | 開始されました | Tigress Financial | Buy |
| 2020-11-09 | アップグレード | UBS | Neutral → Buy |
| 2020-07-14 | 開始されました | Evercore ISI | In-line |
| 2020-07-13 | 開始されました | BofA Securities | Buy |
| 2020-07-13 | 開始されました | Citigroup | Neutral |
| 2020-07-13 | 開始されました | Cowen | Outperform |
| 2020-07-13 | 開始されました | Goldman | Neutral |
| 2020-07-13 | 開始されました | JP Morgan | Neutral |
| 2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 開始されました | SunTrust | Buy |
| 2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
Vanguard Group Inc. Has $952.90 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
(RPRX) Investment Analysis and Advice - news.stocktradersdaily.com
Is Royalty Pharma plc (RPRX) The Most Profitable Biotech Stock To Buy Right Now? - Yahoo
Korea Investment CORP Grows Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Norges Bank Takes Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Is Royalty Pharma Plc (RPRX) the Most Undervalued Healthcare Stock to Buy According to Analysts? - Yahoo Finance
Elo Mutual Pension Insurance Co Grows Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Sees Unusually Large Options Volume (NASDAQ:RPRX) - MarketBeat
8 Most Undervalued Healthcare Stocks to Buy According to Analysts - Insider Monkey
Brandywine Global Investment Management LLC Raises Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Homestead Advisers Corp Grows Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Corient Private Wealth LLC Purchases 21,383 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
7 Most Profitable Biotech Stocks To Buy Right Now - Insider Monkey
Royalty Pharma (NASDAQ:RPRX) Sees Strong Trading VolumeHere's Why - MarketBeat
KLP Kapitalforvaltning AS Invests $3.15 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Has $47.68 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Teacher Retirement System of Texas Raises Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Virtu Financial LLC Invests $467,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
4 Healthcare Stocks With Massive Gains—and More to Come - Benzinga
Sava Infond d.o.o. Makes New Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma pullback a buying opportunity, says Citi - TipRanks
UBS maintains neutral Royalty Pharma stock with $33 target By Investing.com - Investing.com UK
UBS Reiterates Neutral Rating on Royalty Pharma (RPRX) - StreetInsider.com
Citi maintains Buy on Royalty Pharma stock with $40 target By Investing.com - Investing.com UK
Royalty Pharma Announces Upcoming Investor Day - The Manila Times
Citi Reiterates Buy Rating on Royalty Pharma (RPRX) - StreetInsider
Royalty Pharma's Investor Day: Strategic Roadmap for Biopharma Innovation Funding - Stock Titan
Sciencast Management LP Invests $998,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stake Boosted by Royal London Asset Management Ltd. - MarketBeat
Thrivent Financial for Lutherans Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Proficio Capital Partners LLC Invests $786,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Fox Run Management L.L.C. Purchases 16,084 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Is Royalty Pharma plc (RPRX) The Best Defensive Stock Amid Market Volatility? - Yahoo Finance
15 Best Defensive Stocks Amid Market Volatility - Insider Monkey
Koss Olinger Consulting LLC Makes New $269,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by HighTower Advisors LLC - MarketBeat
(RPRX) Technical Data - Stock Traders Daily
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Twin Tree Management LP - MarketBeat
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
8.83%
大文字化:
|
ボリューム (24 時間):